Unable to display view head.php file not found.
In 2002, the American Cancer Society (ACS) became the first professional organization to include the option of
HPV co-testing in women age ≥30. Over the years, ACOG also endorsed HPV co-testing. In the year 2012, on
the right side of the screen, we have two sets of new guidelines from the:
[65] Saslow, D. et al. CA Cancer J . Clin. 2002;52:342-362.
[66] SPSTF. Screening for Cervical Cancer. Accessed January 2003.
Available at: http://www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr.pdf.
[67] Wright, T et al. Obstet. Gynecol. 2004;103:304–9.
[68] Wright, T. et al. J. Low. Genit.Tract Dis. 2007;11(4):201-22.
[69] American Society for Colposcopy and Cervical Pathology. HPV Genotyping Clinical Update. 2009.
Available at: http://www.asccp.org/Portals/9/docs/pdfs/Consensus%20Guidelines/clinical_update_20090408.pdf.
[46] Cervical cytology screening. ACOG Practice Bulletin No.109. American College of Obstetrics and Gynecology. Obstet Gynecol 2009; 114:1409-1420
[70] Saslow, D. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the prevention and detection of cervical cancer. Am J. Clin Pathol 2012;137:516-542.
[71] Moyer, VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation state. Annal of Internal Medicine 2012.
Available at: http://www.annals.org/content/early/2012/03/14/0003-4819-156-12-201206190-00424.full.